Endocrine Society Learning Center

Log-in / Create Account

Session Information

2010 Clinical Endocrinology Update

Click here to go to the previous page

Diabetes & Pregnancy

Track : Saturday October 2, 2010

Program Code: 430

Date: Saturday, October 2, 2010

Time: 8:30 AM to 9:15 AM EST

Location: Constellation Ballroom 1

SPEAKER :

Lois Jovanovic, MD, Sansum Diabetes Res Inst
Disclosure: please refer to the activity landing page for complete disclosure information.

Dr. Jovanovič completed her undergraduate degree from Columbia University, and a master�s degree in Hebrew Literature from The Jewish Theological Seminary in New York, NY. She received her medical degree from The Albert Einstein College of Medicine in New York, NY, and completed her training and fellowship in Internal Medicine, Endocrinology and Metabolism at the New York Hospital, Cornell University Medical College. Jovanovič�s pioneering work in diabetes and pregnancy began with her premise that a diabetic woman�s chances of having a healthy baby could be on a par with a healthy, non-diabetic woman. In her beginning year of fellowship at Cornell University, New York Hospital, her first research study showed that strict monitoring and absolute normalization of blood glucose could yield healthy babies. A year later, she published a larger trial of 52 diabetic women that showed conclusively that diabetic women, even those with severe disease, could have healthy babies (Am J Med 1981; 71: 921�27). Jovanovič proceeded to develop a program to monitor a woman�s blood glucose around the clock and provide treatment strategies to achieve and maintain normal blood glucose concentrations throughout pregnancy. These protocols for intensive insulin delivery now set the standard for strict glucose control in pregnancy. Early in her career she became a principal investigator of the Cornell program for both the Diabetes in Early Pregnancy Study, and the Diabetes Control and Complications Trial (DCCT) a decade-long multicentre clinical trial, which showed that strict glucose control could reduce risk of long-term complications. These studies provided important information about the prevention of birth defects and perinatal complications in pregnancy. For the past 13 years Jovanovič has been CEO & Chief Scientific Officer of Sansum Diabetes Research Institute. Under her leadership, the Institute has become a center of excellence for diabetes and pregnancy. Through community outreach education, teaching and working one-on-one with thousands of pregnant women in the Latina population, she has changed the world of diabetes and pregnancy. She is responsible for establishing global guidelines of care adopted by the International Diabetes Federation and travels extensively throughout the world teaching her protocols to physicians, nurses, dietitians, and educators. In December 2009 she attended the opening of the new Bildirici Center for Diabetes Care and Research in Netanya, Israel where all of their nurses had been trained in her protocols. Throughout her research Dr. Jovanovič has continued to focus on how understanding diabetes in pregnant women may help to broaden knowledge and treatment options for all people with diabetes. Always in the forefront of research, Dr. Jovanovic and other staff members are currently working on the development of an artificial pancreas in collaboration with the Department of Chemical Engineering at the University of California Santa Barbara. Jovanovič�s numerous honors, awards, appointments, and publications of over 500 articles in the fields of diabetes, metabolism, nutrition, obstetrics and gynecology, perinatology and engineering of a glucose-controlled insulin delivery device can be viewed on her more extensive curriculum vitae.

Description

MTP Session

Audio Synchronized to PowerPoint

(Code: 430)

This session is a part of:

Complete Clinical Endocrinology Update Compilation

Handout Online

(Code: 430)

This session is a part of:

Complete Clinical Endocrinology Update Compilation